Paraneoplastic pemphigus
Severe autoimmune blistering · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A severe autoimmune blistering disease driven by an underlying malignancy (often lymphoma/CLL), dominated by refractory, painful mucositis with polymorphous skin lesions, and a risk of fatal airway involvement (bronchiolitis obliterans). Immunosuppression and tumour treatment are key.
Figures & algorithms
Assessment
Investigations
- Severe, treatment-resistant oral/conjunctival mucositis + polymorphous skin
- Biopsy and specific antibodies; CT to find an underlying malignancy
- Assess for respiratory involvement
Management
- Urgent dermatology and oncology/haematology involvement
- Immunosuppression (corticosteroids and steroid-sparing agents)
- Treat the underlying malignancy
- Intensive supportive/skin/mucosal care; monitor the airway
- Recognise the high mortality
Drugs & doses
Immunosuppression
Treat underlying malignancy
Supportive care
Disposition
Dermatology/oncology.
Severe refractory mucositis with skin blistering is paraneoplastic pemphigus until proven otherwise - hunt for a lymphoma and watch the airway.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.
